{"version":"1.0","provider_name":"Cloudbreak Pharma, Inc.","provider_url":"https:\/\/cloudbreakpharma.com\/zh","author_name":"Anna Fung","author_url":"https:\/\/cloudbreakpharma.com\/zh\/author\/fung_annacloudbreakpharma-com\/","title":"Dissemination of Corporate Communications - Cloudbreak Pharma, Inc.","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"HlhVfh81m5\"><a href=\"https:\/\/cloudbreakpharma.com\/zh\/investor-relations\/dissemination-of-corporate-communications\/\">\u4f20\u9001\u516c\u53f8\u901a\u8baf<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cloudbreakpharma.com\/zh\/investor-relations\/dissemination-of-corporate-communications\/embed\/#?secret=HlhVfh81m5\" width=\"600\" height=\"338\" title=\"\u300a Dissemination of Corporate Communications \u300b\u2014Cloudbreak Pharma, Inc.\" data-secret=\"HlhVfh81m5\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/cloudbreakpharma.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","description":"Arrangement of Electronic Dissemination of Corporate Communications Pursuant to new Rule 2.07A1 of the Rules (the \u201cListing Rules\u201d) Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the \u201cStock Exchange\u201d) and the articles of association of Cloudbreak Pharma Inc. (the \u201cCompany\u201d), the Company will disseminate the future corporate communications of the [&hellip;]"}